Showing results (1401-1410 of 5,535) with videos related to

Sort By:
Pageof 554
Inflammatory Bowel Diseases|September 19, 2019
The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar EraAbhinav Vasudevan, Francis Ip, Danny Liew, et al.
Inflammatory Bowel Diseases|September 28, 2019
Utilization of Diagnostic Imaging and Ionization Radiation Exposure Among an Inflammatory Bowel Disease Inception CohortGeoffrey C Nguyen, Daniel Low, Rachel Y Chong, et al.
Inflammatory Bowel Diseases|September 28, 2019
Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel DiseaseHamzah Abu-Sbeih, Yinghong Wang
Inflammatory Bowel Diseases|September 28, 2019
Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United StatesMillie D Long, Timothy W Smith, Marco Dibonaventura, et al.
Inflammatory Bowel Diseases|October 7, 2019
Parental Education May Differentially Impact Pediatric Inflammatory Bowel Disease Phenotype RiskMahesh Krishna, Aziza Salako, Tatiana Fofanova, et al.
Inflammatory Bowel Diseases|February 2, 2021
Trends and Outcomes of Acute Diverticulitis in Inflammatory Bowel Disease: A Propensity-matched National StudyRajat Garg, Abdul Mohammed, Amandeep Singh, et al.
Inflammatory Bowel Diseases|February 2, 2021
Tissue Proteomic Approaches to Understand the Pathogenesis of Inflammatory Bowel DiseaseMontserrat Baldan-Martin, María Chaparro, Javier P Gisbert
Inflammatory Bowel Diseases|February 3, 2021
Evaluation of a U.S. National Cohort to Determine Utilization in Colectomy Rates for Ulcerative Colitis Among EthnicitiesAbhishek Bhurwal, Carlos D Minacapelli, Anish Patel, et al.
Inflammatory Bowel Diseases|January 16, 2021
Phenotype and Natural History of Children With Coexistent Inflammatory Bowel Disease and Celiac DiseaseMatteo Bramuzzo, Paolo Lionetti, Erasmo Miele, et al.
Inflammatory Bowel Diseases|January 27, 2021
LRRC19 Promotes Permeability of the Gut Epithelial Barrier Through Degrading PKC-ζ and PKCι/λ to Reduce Expression of ZO1, ZO3, and OccludinXiaomin Su, Jianmei Wei, Houbao Qi, et al.
Pageof 554